Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Experts’ Interviews

Home » Experts’ Interviews
  • Dr. Hongzhou Lu: NAD Management is Key for HIV Patients, Not Just Changing Medication

    2024.01.14
  • Dr. Wei Cao: Focus on Managing HIV Complications, Further Improving Patient Survival

    2024.01.14
  • SGBCC  International Dialogue| Dr. Li Zhu & Dr. Giuseppe Curigliano Discuss the Need for Adjuvant Therapy After Achieving pCR in Neoadjuvant Treatment

    2024.01.14
  • Dr. Jian Zhang Discusses with Dr. Harbeck: Is Chemotherapy Necessary for ER+/HER2- Breast Cancer Patients with Low Genetic Risk but High Clinical Risk

    2024.01.14
  • Unresolved Issues in Pediatric Hepatitis B Treatment Guidelines

    2024.01.12
  • The Treatment and Clinical Cure of Childhood Hepatitis B

    2024.01.10
  • From “Clinical Cure” to “Disease Cure” – The Long-term Treatment of Chronic Hepatitis B

    2024.01.09
  • Dr. Lai Wei talk about the Renaming of NAFLD to MASLD, Exploration of the Hepatitis B Research Paradigm, and Highlights from the 2023 EASL Congress

    2024.01.03
  • Doctor Tarik Asselah: Beyond Liver Cancer, Viral Hepatitis Is Also Linked to Some Extrahepatic Malignancies

    2024.01.02
  • Doctor Tom Hemming Karlsen Explains the EASL- The Lancet Liver Commission Initiative to Improve European Liver Health and Its Implementation Progress

    2024.01.02
  • Treatment Options for Early Liver Cancer, Strategies for Preventing Recurrence, and the Application of New Molecular Technologies in Tumour

    2024.01.02
  • Dr. Jing Zhang: Team’s 7 Achievements in the Fields of Fatty Liver, Cirrhosis, and Hepatitis C, Research Insights, and Future Directions

    2023.12.22
«previous next»
Recent Posts
  • Strategy for Intensification: Efficacy and Safety of BCG Plus ICI in BCG-Naive High-Risk NMIBC Based on 2,590 Patients
  • Shifting Paradigms in MIBC Diagnosis: How Multimodal Imaging Staging Optimizes Clinical Decision-Making 
  • 80% CR Rate! SIM0237 Demonstrates Potent Anti-tumor Activity and Favorable Tolerability in BCG-unresponsive High-risk NMIBC
  • 52.8% ORR and 87.3% 9-Month PFS Rate: Fruquintinib plus Serplulimab Shows Remarkable Promise in 1st-Line nccRCC 
  • A Predictive Model for BCG-Unresponsiveness and Progression Based on Five Clinical Factors: A Study of 2,211 Patients 
Recent Comments
    Archives
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top